Use of glial derived neurotrophic factor (GDNF) was first identified by Lin and colleagues [115] as a potential treatment for PD because of its ability to increase the dopamine uptake in, and the survival of, embryonic ventral midbrain dopaminergic neurons [116]. This evidence concerns the gene GDNF and Parkinson disease.